Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T CON and increases their thymic output

被引:20
作者
Bruinsma, Marieke
van Soest, Peter L.
Leenen, Pieter J. M.
Lambrecht, Bart N.
Cupedo, Tom
Loewenberg, Bob
Cornelissen, Jan J.
Braakman, Eric
机构
[1] Erasmus Univ, Med Ctr, Dept Hematol, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Immunol, Rotterdam, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Pulm Med, Rotterdam, Netherlands
关键词
D O I
10.4049/jimmunol.179.11.7424
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Keratinocyte growth factor (KGF) has been shown to reduce the incidence and severity of graft-versus-host disease by prevention of epithelial damage and by modulating alloreactivity. Since regulatory T cells (Treg) play a crucial role in immune modulation, we evaluated the effects of exogenous KGF on peripheral CD4(+)Foxp3(+) Treg and the generation of Treg in the thymus of normal mice. A 3-day course of KGF induced a rapid selective increase in the number of highly suppressive CD4(+)Foxp3(+) Treg. Blood Treg numbers remained elevated for >2 mo, but the frequency normalized after 2 wk due to a concomitant increase in CD4(+)Foxp3(-) T cells. Analysis of single joint TCR excision circles frequency and Ki-67 expression in peripheral blood Treg showed that the early selective increase of Treg was predominantly accounted for by peripheral expansion. Thymectomy before KGF administration did not affect the early selective increase of Treg but abrogated the late increase in CD4(+) T cell numbers, thereby showing its dependence on thymic output. Collectively, these results show that KGF induces an increase in blood CD4(+)Foxp3(+) Treg numbers via two independent mechanisms. First by selective peripheral expansion of Treg and thereafter by enhanced thymic output of newly developed Treg.
引用
收藏
页码:7424 / 7430
页数:7
相关论文
共 32 条
[1]   Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration [J].
Alpdogan, Ö ;
Hubbard, VM ;
Smith, OM ;
Patel, N ;
Lu, S ;
Goldberg, GL ;
Gray, DH ;
Feinman, J ;
Kochman, AA ;
Eng, JM ;
Suh, D ;
Muriglan, SJ ;
Boyd, RL ;
van den Brink, MRM .
BLOOD, 2006, 107 (06) :2453-2460
[2]   Quantification of newly developed T cells in mice by real-time quantitative PCR of T-cell receptor rearrangement excision circles [J].
Broers, AEC ;
Meijerink, JPP ;
van Dongen, JJM ;
Posthumus, SJ ;
Löwenberg, B ;
Braakman, E ;
Cornelissen, JJ .
EXPERIMENTAL HEMATOLOGY, 2002, 30 (07) :745-750
[3]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[4]   A dose effect of IL-7 on thymocyte development [J].
El Kassar, N ;
Lucas, PJ ;
Klug, DB ;
Zamisch, M ;
Merchant, M ;
Bare, CV ;
Choudhury, B ;
Sharrow, SO ;
Richie, E ;
Mackall, CL ;
Gress, RE .
BLOOD, 2004, 104 (05) :1419-1427
[5]   Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen [J].
Ellison, CA ;
Natuik, SA ;
Fischer, JMM ;
McIntosh, AR ;
Scully, SA ;
Bow, EJ ;
Danilenko, DM ;
Hayglass, KT ;
Gartner, JG .
JOURNAL OF CLINICAL IMMUNOLOGY, 2004, 24 (02) :197-211
[6]   Regulation of thymic epithelium by keratinocyte growth factor [J].
Erickson, M ;
Morkowski, S ;
Lehar, S ;
Gillard, G ;
Beers, C ;
Dooley, J ;
Rubin, JS ;
Rudensky, A ;
Farr, AG .
BLOOD, 2002, 100 (09) :3269-3278
[7]   Keratinocyte growth factor expression and activity in cancer: Implications for use in patients with solid tumors [J].
Finch, Paul W. ;
Rubin, Jeffrey S. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (12) :812-824
[8]   Developmental regulation of Foxp3 expression during ontogeny [J].
Fontenot, JD ;
Dooley, JL ;
Farr, AG ;
Rudensky, AY .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (07) :901-906
[9]  
FRY H, 2002, TEACH HIGH EDUC, V7, P99
[10]   Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation [J].
Hoffmann, P ;
Ermann, J ;
Edinger, M ;
Fathman, CG ;
Strober, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :389-399